Alexander Bick

Jan 7, 2025 | hoover.org | Alexander Bick

MyHoover delivers a personalized experience at Hoover.org. In a few easy steps, create an account and receive the most recent analysis from Hoover fellows tailored to your specific policy interests. Watch this video for an overview of MyHoover. Create Account

Jan 3, 2025 | stlouisfed.org | Alexander Bick

The number of people who recently immigrated to the U.S. varies greatly among data sources. What might an undercount in recent immigrants mean for the U.S. unemployment rate?

Jun 12, 2024 | nature.com | Aoxing Liu |Giulio Genovese |Yajie Zhao |Matti Pirinen |Xiaoxi Liu |Bryan R. Gorman | +15 more

AbstractMosaic loss of the X chromosome (mLOX) is the most common clonal somatic alteration in leukocytes of female individuals1,2, but little is known about its genetic determinants or phenotypic consequences. Here, to address this, we used data from 883,574 female participants across 8 biobanks; 12% of participants exhibited detectable mLOX in approximately 2% of leukocytes. Female participants with mLOX had an increased risk of myeloid and lymphoid leukaemias.

May 1, 2024 | warontherocks.com | Alexander Bick |Hal Brands |Andrea Kendall-Taylor |Ryan Evans

Ryan sat down with three friends to talk about the war in Ukraine through the lens of a new edited volume on the topic. Enjoy this conversation with Andrea Kendall-Taylor (former CIA), Hal Brands, and Alexander Bick (former National Security Council staff), which surfaces some important disagreements and debates about the war and international order. Oh, and also buy War in Ukraine: Conflict, Strategy, and the Return of a Fractured World.

Oct 30, 2023 | nature.com | Yasminka A. Jakubek |Adrienne M. Stilp |Justin Wong |Zuhal Özcan |Kathleen C. Barnes |Joshua C. Bis | +22 more

AbstractMegabase-scale mosaic chromosomal alterations (mCAs) in blood are prognostic markers for a host of human diseases. Here, to gain a better understanding of mCA rates in genetically diverse populations, we analyzed whole-genome sequencing data from 67,390 individuals from the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine program.